Evaluation of multiorganotrophic factor HGF on the repression of bleomycin induced lung injury and fibrosis in mice

多器官营养因子HGF抑制博来霉素诱导的小鼠肺损伤和纤维化的评价

基本信息

项目摘要

To examine the involvement of HGF in lung regeneration after injury, the murine lung injured by bleomycin (BLM) with or without administration of human recombinant HGF was studied. Mice 8 to 10 weeks old received BLM (100mg/kg/7days) with continuous s.c.infusion with a minipump (model 2001, Alza Corp.) for lung injury. Low dose HGF (50mug/mouse/7days) and high dose HGF (280mug/mouse/14day) were administrated intraperitoneally. (1)In the examination using low dose HGF,HGF or vehicle was administrated as a i.p.infusion. Two and 4 weeks after treatment, groups of mice were sacrificed. With histologic study, simultaneous administration of low dose HGF with BLM apparently repressed the inflammatory process and showed less fibrotic lesions. Analysis by the numerical fibrotic scale and the point counting method revealed that the grade of fibrotic changes of the lung in the mice using HGF were significantly smaller than those in the mice without HGF at 4 weeks. (2) In the examination with high … More dose HGF,mice were devided into 3 groups. Mice of group I and II received high dose HGF by i.p.infusion from day 1 to 14, and from day 15 to 28, respectively, and group III received vehicle from day 1 to 14. Four weeks after treatment, mice were sacrificed. In comparison with group III (BLM alone), the histologic findings of group I and II revealed that lung damages were apparently repressed. The grades of lung injury of group I,II and III,estimated by the numerical scale, were 2.09 (]SY.+-.]) 0.31,1.97 (]SY.+-.]) 0.24, and 4.91 (]SY.+-.]) 0.14, respectively. The score in group I and II were significantly lower than group III (p<0.001 : ANOVA). These results indicate that administration of HGF in different phases equally repressed BLM induced fibrotic changes in lung. (3) The concentration of HGF in lung, liver kidney at 3 days after initial administration of continuous i.p. of HGF 333 and 50 mug/mouse/7days, were 1.96 (]SY.+-.]) 0.04,47.24 (]SY.+-.]) 14.27,12.10 (]SY.+-.]) 0.71ng/g・tissue, 0.63 (]SY.+-.]) 0.27,5.94 (]SY.+-.]) 2.37,1.62 (]SY.+-.]) 0.18 ng/g・tissue, respectively. Less
为了检测HGF在损伤后肺再生中的参与,研究了在施用或不施用人重组HGF的情况下由博莱霉素(BLM)损伤的小鼠肺。8至10周龄的小鼠接受BLM(100 mg/kg/7天),用微型泵(型号2001,Alza Corp.)治疗肺部损伤腹腔注射低剂量HGF(50 μ g/小鼠/7天)和高剂量HGF(280 μ g/小鼠/14天)。(1)In使用低剂量HGF、HGF或赋形剂的检查以腹膜内输注的方式施用。治疗后2周和4周,处死各组小鼠。组织学研究表明,低剂量HGF与BLM同时给药明显抑制了炎症过程,并显示出较少的纤维化病变。通过数值纤维化量表和点计数法的分析显示,在4周时,使用HGF的小鼠的肺纤维化变化的等级显著小于未使用HGF的小鼠。(2)在考试中, ...更多信息 HGF剂量组,将小鼠分为3组。组I和组II的小鼠分别从第1天至第14天和从第15天至第28天通过腹膜内输注接受高剂量HGF,组III从第1天至第14天接受媒介物。处理后四周,处死小鼠。与组III(BLM单独)相比,组I和组II的组织学结果显示,肺损伤明显受到抑制。I、II、III组的肺损伤程度按数值评分法分别为2.09([SY. ±.])0.31,1.97(]SY.+-.])0.24和4.91([SY. ±.])0.14,分别。组I和组II的评分显著低于组III(p<0.001:ANOVA)。这些结果表明,在不同阶段给予HGF同样抑制BLM诱导的肺纤维化变化。(3)连续腹腔注射HGF 333和50 μ g/小鼠/7天后第3天,肺、肝、肾中HGF浓度分别为1.96(± SD)和1.96(± SD)。0.04,47.24(]SY.+-.])14.27,12.10(]SY.+-.])0.71ng/g·组织,0.63([SY. ±.])0.27,5.94(]SY.+-.])2.37,1.62(]SY.+-.])0.18 ng/g·组织。少

项目成果

期刊论文数量(78)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nukiwa T et al.: "Preliminary report on DU-6859a for lower respiratony tract infection" J Infect Chemother. 1. 201-206 (1996)
Nukiwa T 等人:“DU-6859a 治疗下呼吸道感染的初步报告”J Infect Chemother。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakayama S,et al.: "Simultaneous or delayd administration of HGF equally suppressed the fibrotic changes of the lung induced by bleomycin in mice." (1996 International Conference, American Thoracic Society, May 1996, New Orleans, Louisiana, USA).
Nakayama S 等人:“同时或延迟施用 HGF 均能抑制博莱霉素引起的小鼠肺部纤维化变化。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
貫和敏博: "特発性間質性疾患の病態及び肺癌の合併" 日本内科学会雑誌. 83. 739-744 (1994)
Toshihiro Nukiwa:“特发性间质性疾病和肺癌并发症的病理学”日本内科学会杂志 83. 739-744 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
貫和敏博: "気管支肺胞洗浄法(BAL)法の臨床ガイドライン" 克誠堂出版, 6-13 (1995)
Toshihiro Kankazu:“支气管肺泡灌洗 (BAL) 的临床指南” Kenseido Publishing,6-13 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yaekashiwa M et al.: "Hepatocyte growth factor (HGF) represses the fibrotic changes in murine lung injury induced by bleomycin. : A morphologic study." J Clin Invest. (submitted).
Yaekashiwa M 等人:“肝细胞生长因子 (HGF) 抑制博来霉素诱导的小鼠肺损伤中的纤维化变化。:一项形态学研究。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NUKIWA Toshihiro其他文献

NUKIWA Toshihiro的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NUKIWA Toshihiro', 18)}}的其他基金

Biological background for non-smoker lung adenocarcinoma : Why do EGFR somatic mutations accumulate on lung adenocarcinoma and on Asian ethnics?
非吸烟者肺腺癌的生物学背景:为什么 EGFR 体细胞突变会在肺腺癌和亚洲种族中积累?
  • 批准号:
    21249052
  • 财政年份:
    2009
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Decrease of type II pneumocyte function by aging in the process oflung fibrosis : multi-aspect evaluation of STAM1 gene
肺纤维化过程中衰老引起的II型肺细胞功能下降:STAM1基因的多方面评价
  • 批准号:
    19390223
  • 财政年份:
    2007
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Activation mutations in EGF receptor kinase have the advantages of cell physiology in the bronchiolar region : Implication of anti-apoptotic signals and lung tumorigenesis and metastasis.
EGF受体激酶的激活突变具有细支气管区域细胞生理学的优势:抗凋亡信号和肺肿瘤发生和转移的意义。
  • 批准号:
    17390240
  • 财政年份:
    2005
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles of HGF and SLPI on the pathophysiology in the inflammatory and neoplastic pulmonary lesions : Mechanisms of defense and regeneration and their aberration in these disease statuses.
HGF 和 SLPI 在炎症和肿瘤性肺部病变病理生理学中的作用:防御和再生机制及其在这些疾病状态中的畸变。
  • 批准号:
    14207027
  • 财政年份:
    2002
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Exploring the administration route of HGF-expressing adenoviral vector (Ad-HGF) and low but local HGF-expression plasmid vector with macroaggregated albumin/polyethyleneiminV(MAA-PEI) for the clinically effective HGF gene transfer therapy.
探索HGF表达腺病毒载体(Ad-HGF)和低但局部HGF表达质粒载体与大聚集白蛋白/聚乙烯亚胺V(MAA-PEI)的给药途径,以用于临床有效的HGF基因转移治疗。
  • 批准号:
    12557056
  • 财政年份:
    2000
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Redundancy and specified function of the serine protease inhibitors, SLPI and elafin, in the airway tracts
丝氨酸蛋白酶抑制剂 SLPI 和 elafin 在气道中的冗余和特定功能
  • 批准号:
    10470150
  • 财政年份:
    1998
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Analysis of cystic fibrosis transmembrane conductance regulator gene in patients with diffuse panbronchiolitis.
弥漫性全细支气管炎患者囊性纤维化跨膜电导调节基因分析
  • 批准号:
    03454235
  • 财政年份:
    1991
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Direct Search for Nucleotide Substitutions Responsible for Defects of Alpha 1-Antitrypsin Molecules in Patients with Pulmonary Emphysema.
直接寻找导致肺气肿患者中α1-抗胰蛋白酶分子缺陷的核苷酸替代。
  • 批准号:
    01440041
  • 财政年份:
    1989
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了